OpportunityTitle: Minor Use Minor Species Development Drugs
Description: Grants will be awarded up to $75,000 or up to $125,000 in total (direct plus indirect) costs per year for up to three (3) years. Please note the dollar limitation will apply to total costs, not direct costs. Applications for the smaller grants ($75,000) may be for any safety or effectiveness study supportive of new animal drug approval or conditional approval of the designated product for a designated intended use. Study proposals for the larger grants ($125,000) must be for studies that are of necessity of unusual complexity, duration, or size. FDA grants policies as described in the HHS Grants Policy Statement http://www.hhs.gov/grantsnet/adminis/gpd/index.htm will apply to the applications submitted and awards made in response to this FOA.Facilities and Administrative (F&amp;A) costs requested by consortium participants are not included in the direct cost limitation. See NOT-OD-05-004.
GrantorContactEmailDescription: Oluyemisi.Akinneye@fda.hhs.gov
GrantorContactText: Oluyemisi (Yemisi) Akinneye &lt;br/&gt;Grants Management Specialist &lt;br/&gt;Phone 301-827-0079
CloseDateExplanation: This FOA has Multiple Receipt Dates.     First application receipt/due date is 02/17/2012; is CURRENTLY POSTED BY THE NIH GUIDE  Second application receipt/due date is 07/20/2012  Third application receipt/due date is 12/07/2012  Fourth application receipt/due date is 08/16/2013  Fifth application receipt/due date is 1/03/2014  Sixth application receipt/due date is 08/15/2014  Seventh application receipt/due date is 1/16/2015